Vane-Tempest said this group of stocks could reap the benefits of increased spending, but advises steering clear of asset-heavy inpatient-focused companies in favor of leaner peers that concentrate on outpatients, diagnostic testing, and big data.“We expect regulations to be supportive of greater use of predictive diagnostics & the global physician community to continue to embrace the surge in demand for telemedicine,” said Vane-Tempest.